Company news

Illumina, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Illumina increases equitable access to STEM education, reaching over 1 million learners

May 1, 2023

Illumina Issues Shareholder Letter and Requests Shareholders Vote for the Illumina Director Nominees on the WHITE Proxy Card

April 30, 2023

Illumina Reports Financial Results for First Quarter of Fiscal Year 2023; Announces Commitment to Accelerate Margin Growth

April 24, 2023

Illumina Urges Shareholders to Vote the WHITE Proxy Card FOR all Nine of Illumina's Nominees

April 19, 2023

Illumina's cloud-based informatics programs recognized for robust, international data privacy protections

April 11, 2023

Illumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients

April 10, 2023

Illumina celebrates 25 years of innovation

April 4, 2023

Illumina to Announce First Quarter 2023 Financial Results on Tuesday, April 25, 2023

April 3, 2023

Illumina's revolutionary NovaSeq X exceeds 200th order milestone in first quarter 2023

April 3, 2023

Illumina Will Appeal FTC Decision in Federal Court, Will Seek US Resolution by Late 2023 or Early 2024

April 2, 2023

Illumina Files Preliminary Proxy, Urging Shareholders to Vote for Its Director Nominees and Withhold for Each Icahn Group Nominee

March 29, 2023

Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease

March 26, 2023

Illumina Issues Statement in Response to Carl Icahn's Letter

March 23, 2023

Illumina Underscores Commitment to Shareholder Value and Responds to Carl Icahn's Statements

March 19, 2023

Illumina launches its first product enabling long- and short-read sequencing on one instrument

March 13, 2023

Illumina Responds to Icahn Partners' Nomination of Directors

March 12, 2023

Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States

March 1, 2023

Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute

February 7, 2023

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022

February 6, 2023

Illumina Appoints Joydeep Goswami Chief Financial Officer

January 31, 2023

Illumina to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023

January 9, 2023

Illumina and Nashville Biosciences Announce Sequencing Agreement with Amgen

January 8, 2023

Illumina Ranks Among Top Scores on Dow Jones Sustainability Index and CDP

December 13, 2022

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022

November 2, 2022

Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States

November 2, 2022

Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research

November 1, 2022

Francis deSouza Recognized as 3BL Media's Responsible CEO of the Year for Innovation and ESG Integration

October 24, 2022

Illumina To Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022

October 23, 2022

Illumina and GenoScreen Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis

October 17, 2022

Illumina to Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022

October 16, 2022

Illumina Launches Strategic Research Collaboration with AstraZeneca to Accelerate Drug Target Discovery

October 10, 2022

Illumina to Announce Third Quarter 2022 Financial Results on Thursday, November 3, 2022

October 5, 2022

Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human Health

September 28, 2022

Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum

September 28, 2022

Illumina Genomics Forum Sold Out, Announces Opportunity to View Innovation Roadmap Session via Livestream

September 25, 2022

John Hancock becomes the first life insurance carrier to offer access to GRAIL's multi-cancer early detection test to customers

September 19, 2022

Illumina to Host Upcoming Investor Day

September 18, 2022

Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold as part of Distinguished Panel on How the Genomics Revolution Is Transforming Patient Care

September 18, 2022

Illumina Accelerator Invests in the Fifth Global Funding Cycle of Startups Advancing Breakthrough Therapeutics, Diagnostics, Women's Health, and Sustainable Agriculture Applications

September 13, 2022

Illumina Genomics Forum to Convene Leading Visionaries to Explore Architecting Health's Radically New Infrastructure

September 11, 2022

llumina Announces Opportunity to View Live Webcast of Illumina Genomics Forum Innovation Roadmap Session Followed by Investor Conference Call

September 7, 2022

Illumina Genomics Forum to Feature Diverse Lineup of Visionary Global Leaders

September 6, 2022

Illumina Intends to Appeal European Commission's Decision in GRAIL Deal

September 5, 2022

Administrative Law Judge Rules in Favor of Illumina in FTC Challenge of GRAIL Deal

August 31, 2022

Illumina Deepens Commitment to Customers in China with New Manufacturing Site

August 29, 2022

Illumina Genomics Forum to Feature Tennis Legend Chris Evert on the Role Genomics Played in her Cancer Fight

August 28, 2022

Illumina Genomics Forum to Feature 23andMe Co-founder and CEO Anne Wojcicki

August 21, 2022

Minderoo Foundation and Illumina Commit $40M AUD to Apply Advanced Genomics to Marine Conservation

August 15, 2022

Illumina Genomics Forum to Feature American Cancer Society CEO Karen Knudsen on the Future of Cancer Genomics

August 14, 2022

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022

August 10, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 50 decks. Every deck is listed under its year.